東湖高新(600133.SH):湖北聯合發展投資集團同意公司發行不超19億元可轉債
格隆匯5月18日丨東湖高新(600133.SH)公告,近日,公司收到了湖北省人民政府國有資產監督管理委員會授權主體湖北省聯合發展投資集團有限公司出具的《關於武漢東湖高新集團股份有限公司公開發行可轉換公司債券的批覆》(鄂聯投綜【2020】54號),同意公司董事會提出的公開發行可轉換公司債券不超過人民幣19億元(含本數)的方案。
本次事項尚需履行公司股東大會審議、中國證監會核准等多項審批程序,公司將嚴格按照有關規定和相關程序,全力做好相關工作,並根據後續進展情況,按照相關規定及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.